President Donald Trump said Thursday his administration has reached an agreement with drugmakers Novo Nordisk and Eli Lilly to lower the cost of their blockbuster GLP-1 weight loss drugs, Wegovy and ...
The US Food and Drug Administration will take steps to streamline the development of generic versions of complex biological drugs, the agency announced Wednesday. The changes are meant to accelerate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback